Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL10815564 | 1.00 | TSHR (0.60) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL9066090 | 1.00 | TSHR (0.60) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL693725 | 1.00 | TSHR (0.60) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL28110589 | 0.93 | TSHR (0.60) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL7994810 | 0.93 | TSHR (0.60) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL31024706 | 0.86 | TSHR (0.69) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL432431 | 0.86 | TSHR (0.69) | TSHRNAPRTTDP1NOTUM | |
| Benzene SCHEMBL28078567 | 0.86 | TSHR (0.69) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL1172941 | 0.86 | TSHR (0.69) | TSHRNAPRTTDP1NOTUM | |
| Pyridine SCHEMBL3103106 | 0.86 | TSHR (0.69) | TSHRNAPRTTDP1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6846922-B1 | Reacting phosphoramidite with hydroxyl group of nucleoside or oligonucleotide linked to solid support in presence of activating reagent comprising at least one pyridinium salt and at least one substituted imidazole | ISIS PHARMACEUTICALS, INC. (US) | 2005-01-25 | — | — | US | disclosed |
| EP-1084134-A4 | ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS | ISIS PHARMACEUTICALS INC (US) | 2004-05-26 | — | — | EP | disclosed |
| US-6642373-B2 | Phosphitylating using pyridinium salt activators; forming phosphorate or phosphorothioate intersugar linkages | ISIS PHARMACEUTICALS, INC. | 2003-11-04 | — | — | US | disclosed |
| US-20030191304-A1 | Activators for oligonucleotide synthesis | IONIS PHARMACEUTICALS, INC. | 2003-10-09 | — | — | US | disclosed |
| US-6274725-B1 | PROVIDING COMPOUND HAVING A HYDROXYL GROUP; REACTING WITH PHOSPHITYLATING REAGENT IN THE PRESENCE OF A PYRIDINUM SALT IN A SOLVENT UNDER CONDITIONS OF TIME, TEMPERATURE AND PRESSURE TO YIELD PHOSPHITYLATED COMPOUND | ISIS PHARMACEUTICALS, INC. | 2001-08-14 | — | — | US | disclosed |
| EP-1084134-A1 | ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999062922-A1 | ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191304-A1 | Activators for oligonucleotide synthesis | ITPA, NUDT1, TYMP | TSHR 4098/4885NAPRT 181/4885TDP1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.